![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RW Milne, PA Sloan, CF McLean, LE Mather, RL Nation, WB Runciman, AJ Rutten and AA Somogyi
School of Pharmacy, University of South Australia, Adelaide.
A sheep preparation was used to examine the regional formation and extraction of morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), relative to the regional extraction of morphine, at four morphine dose rates. On separate occasions, four ewes received a 15-min loading infusion of morphine sulfate, followed by a constant infusion at 2.5, 5, 10, or 20 mg/hr for an additional 5.75 hr. During the 5th to 6th hr of infusion, blood samples were collected simultaneously from the aorta, pulmonary artery, hepatic vein, hepatic portal and renal veins, posterior vena cava, and coronary and sagittal sinuses. Urine was collected for 48 hr. Morphine, M3G, and M6G in plasma and urine were determined simultaneously by HPLC. The blood/plasma concentration ratio (lambda) for morphine, M3G, and M6G was determined in spiked "blank" blood. Steady-state plasma concentrations were achieved during the sampling period, and dose-normalized concentrations were independent of the infusion rate. There was significant (p < 0.05) extraction (mean +/- SD) of morphine by the liver (0.676 +/- 0.014) and kidney (0.602 +/- 0.039), net extraction of M3G (0.106 +/- 0.046) and M6G (0.104 +/- 0.030) by the kidney, and net formation of M3G (-0.057 +/- 0.017) by the gut. The mean lambda for morphine, M3G, and M6G was 1.25 +/- 0.17, 0.80 +/- 0.03, and 0.82 +/- 0.09, respectively. The mean total body clearance of morphine with respect to blood was 1.58 +/- 0.27 liters/min. Mean (+/-SD) percentage urinary recoveries as morphine, M3G, and M6G were 14.7 +/- 8.5, 75.4 +/- 11.1, and 0.49 +/- 0.39, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Garland, K. M. Abildskov, S. Taylor, K. Benzeroual, C. S. Caspersen, S. E. Arroyo, T.-w. Kiu, B. Reznik, P. Weldy, S. S. Daniel, et al. FETAL MORPHINE METABOLISM AND CLEARANCE ARE CONSTANT DURING LATE GESTATION Drug Metab. Dispos., April 1, 2006; 34(4): 636 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, K. W. Riggs, and D. W. Rurak STEREOSELECTIVE PHARMACOKINETICS OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS IN PREGNANT SHEEP Drug Metab. Dispos., February 1, 2004; 32(2): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Upton, G. L. Ludbrook, A. M. Martinez, C. Grant, and R. W. Milne Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions Br. J. Anaesth., June 1, 2003; 90(6): 750 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Edgecombe, G. L. Stretch, and P. J. Hayball Oleuropein, an Antioxidant Polyphenol from Olive Oil, Is Poorly Absorbed from Isolated Perfused Rat Intestine J. Nutr., December 1, 2000; 130(12): 2996 - 3002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Shanahan, A. M. Evans, and R. L. Nation Disposition of Morphine in the Rat Isolated Perfused Kidney: Concentration Ranging Studies J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1518 - 1525. [Abstract] [Full Text]
|
|
|
|
|
|
R. W. Milne, C. F. McLean, L. E. Mather, R. L. Nation, W. B. Runciman, A. J. Rutten, and A. A. Somogyi Influence of Renal Failure on the Disposition of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Sheep during Intravenous Infusion with Morphine J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 779 - 786. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
